$4.10
0.71[20.94%]
At close: Apr 26
$4.10
0[0.00%]
After Hours: 5:26PM EDT
Eliem Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Eliem Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | PM | ELYM | Q1 | -$0.84 | — | — | — | $0.00 | — | — | — | Get Alert |
03/28/2024 | PM | ELYM | Q4 | -$0.29 | — | -$0.13 | — | $0.00 | — | $0.00 | — | Get Alert |
11/14/2023 | PM | ELYM | Q3 | -$0.37 | — | -$0.15 | — | $0.00 | — | $0.00 | — | Get Alert |
08/10/2023 | AM | ELYM | Q2 | -$0.56 | -$0.16 | -$0.19 | -18.75% | $0.00 | — | $0.00 | — | Get Alert |
05/11/2023 | PM | ELYM | Q1 | -$0.50 | -$0.25 | -$0.84 | -236.00% | $0.00 | — | $0.00 | — | Get Alert |
03/06/2023 | PM | ELYM | Q4 | -$0.40 | -$0.38 | -$0.29 | 23.68% | $0.00 | — | $0.00 | — | Get Alert |
11/14/2022 | AM | ELYM | Q3 | -$0.70 | -$0.43 | -$0.37 | 13.95% | $0.00 | — | $0.00 | — | Get Alert |
08/15/2022 | AM | ELYM | Q2 | -$3.11 | -$0.53 | -$0.56 | -5.66% | $0.00 | — | $0.00 | — | Get Alert |
05/16/2022 | AM | ELYM | Q1 | -$5.70 | -$0.56 | -$0.50 | 10.71% | $0.00 | — | $0.00 | — | Get Alert |
03/07/2022 | PM | ELYM | Q4 | -$4.99 | -$0.62 | -$0.40 | 35.48% | $0.00 | — | $0.00 | — | Get Alert |
11/08/2021 | PM | ELYM | Q3 | -$1.46 | -$0.58 | -$0.70 | -20.69% | — | — | $0.00 | — | Get Alert |
09/13/2021 | PM | ELYM | Q2 | -$1.12 | — | -$3.11 | — | $0.00 | — | $0.00 | — | Get Alert |
Eliem Therapeutics (ELYM) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 28, 2024 for Q4.
The Actual EPS was $-0.13, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.